Mucinex DM
NDC 67751-171, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, tablet, extended release, from Navajo Manufacturing Company Inc..
- Product NDC
- 67751-171
- Status
- Listed
- Labeler
- Navajo Manufacturing Company Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA021620
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67751-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE30 mg/1
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67751-171-01 | 67751017101 | 1 POUCH in 1 CARTON (67751-171-01) / 2 TABLET, EXTENDED RELEASE in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 67751-171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67751-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67751-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.